SVRA - Savara Inc - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - SVRA (1160308)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
36 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2023-07-17
SVRAYang Rick10%P - Purchase$3.00+333,33324,471,264+1%+$999,999
2023-07-17
SVRAWalker Paul Edward10%P - Purchase$3.00+333,33324,471,264+1%+$999,999
2023-07-17
SVRASandell Scott D10%P - Purchase$3.00+333,33324,471,264+1%+$999,999
2023-07-17
SVRAMathers Edward T10%P - Purchase$3.00+333,33324,471,264+1%+$999,999
2023-07-17
SVRAMakhzoumi Mohamad10%P - Purchase$3.00+333,33324,471,264+1%+$999,999
2023-07-17
SVRAFlorence Anthony A. Jr.10%P - Purchase$3.00+333,33324,471,264+1%+$999,999
2023-07-17
SVRAChang Carmen10%P - Purchase$3.00+333,33324,471,264+1%+$999,999
2023-07-17
SVRABehbahani Ali10%P - Purchase$3.00+333,33324,471,264+1%+$999,999
2023-07-17
SVRABaskett Forest10%P - Purchase$3.00+333,33324,471,264+1%+$999,999
2023-07-17
SVRAGrowth Equity Opportunities 17, LLC10%P - Purchase$3.00+333,33324,471,264+1%+$999,999
2023-06-26
SVRAPratt Raymond DennisChief Medical OfficerP - Purchase$2.93+6,500160,000+4%+$19,045
M
2023-05-24
SVRARamsay David ADirP - Purchase$2.59+100,0002,201,142+5%+$258,529
M
2022-12-29
SVRARamsay David ADirP - Purchase$1.54+36,0002,101,142+2%+$55,586
M
2022-12-23
SVRARamsay David ADirP - Purchase$1.45+19,0002,065,142+1%+$27,588
2022-12-22
SVRAPratt Raymond DennisChief Medical OfficerP - Purchase$1.54+3,500153,500+2%+$5,402
M
2022-12-20
SVRARamsay David ADirP - Purchase$1.48+45,0002,046,142+2%+$66,434
M
2022-12-16
SVRARamsay David ADirP - Purchase$1.50+54,8902,001,142+3%+$82,105
M
2022-11-22
SVRARamsay David ADirP - Purchase$1.43+20,1051,946,252+1%+$28,652
M
2022-11-17
SVRARamsay David ADirP - Purchase$1.37+50,0051,926,147+3%+$68,441
M
2022-09-23
SVRARamsay David ADirP - Purchase$1.39+135,0001,876,142+8%+$187,093
M
2022-09-16
SVRARamsay David ADirP - Purchase$1.45+8,0001,741,1420%+$11,562
M
2022-09-06
SVRARamsay David ADirP - Purchase$1.40+32,0001,733,142+2%+$44,722
M
2022-08-30
SVRARamsay David ADirP - Purchase$1.42+100,0001,701,142+6%+$141,932
M
2022-06-17
SVRARamsay David ADirP - Purchase$1.38+100,0001,601,142+7%+$138,380
M
2021-12-29
SVRARamsay David ADirP - Purchase$1.28+50,0001,501,142+3%+$64,035
2021-12-17
SVRALowrance David LCFOP - Purchase$1.14+4,000142,793+3%+$4,569
M
2021-12-15
SVRARamsay David ADirP - Purchase$1.11+40,0001,451,142+3%+$44,485
2021-12-10
SVRARamsay David ADirP - Purchase$1.04+35,0001,411,142+3%+$36,365
M
2021-12-07
SVRARamsay David ADirP - Purchase$1.05+25,0001,376,142+2%+$26,214
2021-12-09
SVRAChowdhury Badrul A.CHIEF MEDICAL OFFICERP - Purchase$1.05+25,000175,000+17%+$26,250
2021-12-08
SVRAPauls MatthewCEOP - Purchase$1.06+6,500383,672+2%+$6,889
M
2021-12-01
SVRARamsay David ADirP - Purchase$1.09+25,0001,351,142+2%+$27,128
2021-12-02
SVRAPauls MatthewCEOP - Purchase$1.10+10,000377,172+3%+$10,954
M
2021-11-30
SVRARamsay David ADirP - Purchase$1.09+25,0001,326,142+2%+$27,157
M
2021-11-18
SVRARamsay David ADirP - Purchase$1.08+200,0001,301,142+18%+$215,393
M
2021-11-18
SVRAPauls MatthewCEOP - Purchase$1.10+22,150367,172+6%+$24,390

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top